FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020026033> ?p ?o ?g. }

• W3020026033 abstract "Abstract Background This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab (Bev) in clinical practice. Methods We retrospectively analyzed mCRC patients who received FOLFOXIRI plus Bev between December 2015 and December 2017. We evaluated the efficacy of PEG-G-CSF as preventing or treating grade 3 or 4 neutropenia, the overall response rate (ORR) according to the Response Evaluation Criteria in Solid Tumors version 1.1, progression-free survival (PFS), overall survival (OS), and adverse events of FOLFOXIRI plus Bev based on the Common Terminology Criteria for Adverse Events version 4.0. Results A total of 26 patients (median age 53.5 years) were included. The ORR rate was 65.3%, the median PFS was 9.6 months (7.2–16.9), and the median OS was 24.2 months (13.6–NA). Grade 3 or 4 neutropenia occurred in 53.8% of the patients, and febrile neutropenia occurred in 7.7%. PEG-G-CSF was given to 77.0% of the patients, including prophylactically ( n = 9) and after the development of grade 3 or 4 neutropenia ( n = 11). No patients experienced grade 3 or 4 neutropenia after the administration of PEG-G-CSF. In seven of the nine patients who received PEG-G-CSF prophylactically (77.8%), no dose adjustment was required. Conclusions PEG-G-CSF is useful in preventing severe neutropenia in mCRC patients treated with FOLFOXIRI plus Bev." @default.
• W3020026033 created "2020-05-01" @default.
• W3020026033 creator A5002562596 @default.
• W3020026033 creator A5012297126 @default.
• W3020026033 creator A5039514890 @default.
• W3020026033 creator A5045163525 @default.
• W3020026033 creator A5047876211 @default.
• W3020026033 creator A5052450644 @default.
• W3020026033 creator A5064316490 @default.
• W3020026033 creator A5066658797 @default.
• W3020026033 creator A5069216523 @default.
• W3020026033 creator A5070643359 @default.
• W3020026033 creator A5077085235 @default.
• W3020026033 creator A5078320729 @default.
• W3020026033 creator A5083889178 @default.
• W3020026033 date "2020-04-28" @default.
• W3020026033 modified "2023-10-13" @default.
• W3020026033 title "Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study" @default.
• W3020026033 cites W1503247057 @default.
• W3020026033 cites W1972469059 @default.
• W3020026033 cites W1982377223 @default.
• W3020026033 cites W1990423062 @default.
• W3020026033 cites W1990971827 @default.
• W3020026033 cites W1992918749 @default.
• W3020026033 cites W1993780950 @default.
• W3020026033 cites W1994978349 @default.
• W3020026033 cites W1997991692 @default.
• W3020026033 cites W2000487326 @default.
• W3020026033 cites W2002814329 @default.
• W3020026033 cites W2023588049 @default.
• W3020026033 cites W2036450045 @default.
• W3020026033 cites W2099191657 @default.
• W3020026033 cites W2100082529 @default.
• W3020026033 cites W2105417870 @default.
• W3020026033 cites W2106833866 @default.
• W3020026033 cites W2106845199 @default.
• W3020026033 cites W2110534467 @default.
• W3020026033 cites W2115170812 @default.
• W3020026033 cites W2115211034 @default.
• W3020026033 cites W2117331468 @default.
• W3020026033 cites W2118385151 @default.
• W3020026033 cites W2121985645 @default.
• W3020026033 cites W2136733759 @default.
• W3020026033 cites W2142195688 @default.
• W3020026033 cites W2149285284 @default.
• W3020026033 cites W2157416388 @default.
• W3020026033 cites W2164788594 @default.
• W3020026033 cites W2171576276 @default.
• W3020026033 cites W2269955197 @default.
• W3020026033 cites W2331170460 @default.
• W3020026033 cites W2337299291 @default.
• W3020026033 cites W2337734501 @default.
• W3020026033 cites W2480743389 @default.
• W3020026033 cites W2513024795 @default.
• W3020026033 cites W2749779586 @default.
• W3020026033 cites W2772503094 @default.
• W3020026033 cites W2787981425 @default.
• W3020026033 cites W2792655657 @default.
• W3020026033 cites W2900337696 @default.
• W3020026033 cites W2937638395 @default.
• W3020026033 cites W324244878 @default.
• W3020026033 doi "https://doi.org/10.1186/s12885-020-06864-8" @default.
• W3020026033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7189469" @default.
• W3020026033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32345249" @default.
• W3020026033 hasPublicationYear "2020" @default.
• W3020026033 type Work @default.
• W3020026033 sameAs 3020026033 @default.
• W3020026033 citedByCount "4" @default.
• W3020026033 countsByYear W30200260332020 @default.
• W3020026033 countsByYear W30200260332021 @default.
• W3020026033 countsByYear W30200260332022 @default.
• W3020026033 crossrefType "journal-article" @default.
• W3020026033 hasAuthorship W3020026033A5002562596 @default.
• W3020026033 hasAuthorship W3020026033A5012297126 @default.
• W3020026033 hasAuthorship W3020026033A5039514890 @default.
• W3020026033 hasAuthorship W3020026033A5045163525 @default.
• W3020026033 hasAuthorship W3020026033A5047876211 @default.
• W3020026033 hasAuthorship W3020026033A5052450644 @default.
• W3020026033 hasAuthorship W3020026033A5064316490 @default.
• W3020026033 hasAuthorship W3020026033A5066658797 @default.
• W3020026033 hasAuthorship W3020026033A5069216523 @default.
• W3020026033 hasAuthorship W3020026033A5070643359 @default.
• W3020026033 hasAuthorship W3020026033A5077085235 @default.
• W3020026033 hasAuthorship W3020026033A5078320729 @default.
• W3020026033 hasAuthorship W3020026033A5083889178 @default.
• W3020026033 hasBestOaLocation W30200260331 @default.
• W3020026033 hasConcept C121608353 @default.
• W3020026033 hasConcept C126322002 @default.
• W3020026033 hasConcept C141071460 @default.
• W3020026033 hasConcept C197934379 @default.
• W3020026033 hasConcept C2776694085 @default.
• W3020026033 hasConcept C2777063308 @default.
• W3020026033 hasConcept C2777793932 @default.
• W3020026033 hasConcept C2777802072 @default.
• W3020026033 hasConcept C2778850193 @default.
• W3020026033 hasConcept C2780259306 @default.
• W3020026033 hasConcept C2780873365 @default.
• W3020026033 hasConcept C2780962732 @default.
• W3020026033 hasConcept C526805850 @default.
• W3020026033 hasConcept C71924100 @default.

• next